The Huxley Morton Podcast

In this episode, we dive into the fascinating journey of Lars Dreesmann, President of Boehringer Ingelheim Fremont. Join us as Lars shares his story of growth, from his early interest in biology to his transition into the pharmaceutical industry, and the challenges he faced relocating to California during the pandemic. Learn about his role at Boehringer, the cultural differences between Germany and the U.S., and the evolution of work practices post-pandemic. Don't miss this engaging conversation about personal and professional growth in the pharma industry!

Adina Pelusio, SVP of Clinical Operations at Kalivir Immunotherapeutics. Adina's journey from a chance job offer to a leading role in biotech is nothing short of motivational. Learn how she navigated her career, the value of saying 'yes' to opportunities, and the importance of mentorship.

This week, we talk to Robert Goldman and Justin Rudolph from Alcoa Consulting about their innovative two-for-one consulting model. If you're a biotech startup or a large CRO, this episode is packed with insights on how to leverage experienced consultants without breaking the bank. Their 360-degree experience in biotech and CRO industries is a game-changer. Listen now!

Networking is key in today's job market! Chiara Invernizzi shares invaluable insights on leveraging LinkedIn and building connections to advance your career. From moving countries to navigating different corporate cultures today we hear Chiara’s challenges and triumphs.

Dr. Sanjeev Chopra, a professor of medicine at Harvard Medical School and Edward Alano, founder of Arrow DX share groundbreaking insights on the intersection of AI, machine learning, and healthcare in our latest podcast episode. Dr. Chopra and Edward discuss their journey and vision for transforming the healthcare industry using cutting-edge technology.

Dive into the inspiring career journey of Chris Howard, a trailblazer in clinical operations and project management in the life sciences sector. From her pioneering contributions to Johnson and Johnson’s wellness programs to shaping the standards of project management in clinical trials, discover the challenges she faced and the heights she reached. ✨  #WomenInSTEM #Leadership

This week James speaks to Dr Daniel Fox on

Transforming Autism research - Building a community for Integration and trials.

Proving the doubters wrong – The Successful SOS Conference

Revolutionising the conference culture and entrepreneurship

This week James speaks to Mike Tush, CEO of Treadwell Therapeutics. Mike shares his fascinating career trajectory, from his early fascination with STEM pursuits to his unexpected journey through pharmaceuticals, biotech, and clinical research.

The discussion delves into his experiences on Wall Street as an equity analyst and hedge fund manager, his transition back into the biotech space, and his role as CEO of Treadwell Therapeutics.

Throughout the conversation, Mike emphasizes the importance of making a difference in patient's lives and the critical role of effective leadership and teamwork in the pharmaceutical industry.

This week James speaks to Lisa Sonneborn about starting her own research site with the money she had saved for her wedding. Subsequently growing and selling that site to joining Ichor and setting up Ichor Clinical. Lisa shares her challenges and wins in building ICorps Clinical as well as sharing her golden rules for life and business.

Tune into Lisa’s story today.

In this episode of the Huxley Morton Podcast, James is joined by Carlos Martin, the Chief Commercial Officer and Head of International at Rocket Pharma.

Carlos shares his journey from working in various roles at Novartis Oncology to embracing the entrepreneurial spirit at Rocket Pharma.

As CCO, he discusses the focus on developing gene therapies for treating rare pediatric conditions. Carlos emphasizes the importance of transitioning the company from a clinical-stage to a commercial-stage biotech firm while aligning with their mission to eradicate rare diseases using gene therapies.

He provides an insight into the challenges and strategies of creating, delivering, and commercializing complex therapeutics.